THE DEAL, AT A GLANCE
From the announcementCellares
01Cell therapy development
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedCellares raised $255M Series C, announced 2023-08-23From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersCellares is positioning its $255M Series C as funding for an integrated development and manufacturing organization and smart factory for cell therapy manufacturing.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Cellares · Financing Record
Explore source-linked visual explanations for Cellares. Unsupported claims are withheld while source review continues.
Record 3281 · Recorded date: 2023-08-23
Explore company records →